Article

GRF receives largest bequest in its history

San Francisco-The Glaucoma Research Foundation (GRF) has received a $3 million bequest, the largest gift in its history.

 

San Francisco-The Glaucoma Research Foundation (GRF) has received a $3 million bequest, the largest gift in its history.

The bequest, which was given by Henry Adolph Sutro, DDS, of Oakland, CA, was made in honor of his ophthalmologist, Andrew G. Iwach, MD.

Dr. Iwach is the executive director of the Glaucoma Center of San Francisco and board chairman of GRF.

“We are incredibly grateful to Dr. Sutro for this remarkable gift,” said Thomas M. Brunner, president and chief executive officer of GRF. “His thoughtful contribution in honor of Dr. Iwach is particularly meaningful, as it is a testament to the quality and excellence of the care and compassion Dr. Iwach provides to all of his patients.”

The bequest will establish the Dr. Henry A. Sutro Family Grant for Research and the Drs. Henry and Frederick Sutro Memorial Lecture.

The lecture will be held each year at the Glaucoma 360 annual meeting. It was created to promote innovation in glaucoma therapy, as well as continuing education program for clinicians to highlight the latest advances in glaucoma management.

For more articles in this issue of Ophthalmology Times eReport, click here.


 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.